A detailed history of E Cio, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, E Cio, Inc. holds 886 shares of LLY stock, worth $685,507. This represents 0.24% of its overall portfolio holdings.

Number of Shares
886
Holding current value
$685,507
% of portfolio
0.24%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jun 06, 2025

BUY
$725.72 - $929.72 $642,987 - $823,731
886 New
886 $732 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $735B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track E Cio, Inc. Portfolio

Follow E Cio, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Cio, Inc., based on Form 13F filings with the SEC.

News

Stay updated on E Cio, Inc. with notifications on news.